{"id":2658,"date":"2020-09-03T10:36:40","date_gmt":"2020-09-03T01:36:40","guid":{"rendered":"https:\/\/bcgblog.kr\/?p=2658"},"modified":"2020-11-13T14:58:46","modified_gmt":"2020-11-13T05:58:46","slug":"covid19-perspectives-15-1-vaccine-therapeutics-outlook-part","status":"publish","type":"post","link":"https:\/\/bcgblog.kr\/covid19-perspectives-15-1-vaccine-therapeutics-outlook-part\/","title":{"rendered":"\ucf54\ub85c\ub09819, BCG Perspectives – \ub9ac\ub354\uac00 \ucc38\uace0\ud574\uc57c\ud560 \uc2dc\ub098\ub9ac\uc624"},"content":{"rendered":"